Gitas Rancanes arsta-kardiologa privatprakse SIA

Research site

Latvia Baznicas Iela 2, 3601 Ventspils, Latvia

2 trials recruiting
Atrial fibrillation · Cardiovascular disorder · Cerebrovascular accident prophylaxis
Adult patients

About Specializations

Gitas Rancanes arsta-kardiologa privatprakse SIA in Ventspils, Latvia specialises in clinical trials of conditions such as Atrial fibrillation, Cardiovascular disorder, Cerebrovascular accident prophylaxis, Hypertension, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

At Gitas Rancanes arsta-kardiologa privatprakse SIA in Ventspils, Latvia, clinical research focuses on cardiovascular diseases and related metabolic conditions, aiming to evaluate new therapeutic strategies that may lower heart‑failure events and improve outcomes for patients with hypertension and type 2 diabetes.

Heart failure and preserved ejection fraction
Combination therapy with SGLT2 inhibitors
Impact of mineralocorticoid receptor antagonists
Management of hypertension in diabetic patients

The site’s two investigator‑led trials explore whether adding novel agents to standard care can reduce cardiovascular death and hospitalizations, offering hope for better disease management in the community.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Baznicas Iela 23601 VentspilsLatvia

Open in maps ↗

Recruiting now: 2 trials
Conditions studied: 6

More sites in Ventspils Latvia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

3 clinical trials

Cardiovascular disorder+2

Recruiting

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug

Latvia

Participants:18–64 years · 65+ years
Substances:BI 690517
Sponsor:Boehringer Ingelheim Espana S.A.

Contact Research Centre

Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

Recruiting

Investigational

Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

Investigational

Latvia

Participants:18–64 years · 65+ years
Substances:Finerenone
Sponsor:Colorado Prevention Center

Contact Research Centre

Atrial fibrillation+2

Not recruiting

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug

Latvia

Participants:18–64 years · 65+ years
Substances:Apixaban
Sponsor:Bayer AG

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites